|
1
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen W, Zheng R, Zeng H and Zhang S: The
updated incidences and mortalities of major cancers in China, 2011.
Chin J Cancer. 34:502–507. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Fearnhead NS, Wilding JL and Bodmer WF:
Genetics of colorectal cancer: Hereditary aspects and overview of
colorectal tumorigenesis. Br Med Bull. 64:27–43. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wolpin BM and Mayer RJ: Systemic treatment
of colorectal cancer. Gastroenterology. 134:1296–1310. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ponting CP, Oliver PL and Reik W:
Evolution and functions of long noncoding RNAs. Cell. 136:629–641.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Whitehead J, Pandey GK and Kanduri C:
Regulation of the mammalian epigenome by long noncoding RNAs.
Biochim Biophys Acta. 1790:936–947. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li L, Feng T, Lian Y, Zhang G, Garen A and
Song X: Role of human noncoding RNAs in the control of
tumorigenesis. Proc Natl Acad Sci. 106:pp. 12956–12961. 2009;
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bartolomei MS, Zemel S and Tilghman SM:
Parental imprinting of the mouse H19 gene. Nature. 351:153–155.
1991. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tabano S, Colapietro P, Cetin I, Grati FR,
Zanutto S, Mandò C, Antonazzo P, Pileri P, Rossella F, Larizza L,
et al: Epigenetic modulation of the IGF2/H19 imprinted domain in
human embryonic and extra-embryonic compartments and its possible
role in fetal growth restriction. Epigenetics. 5:313–324. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Poirier F, Chan CT, Timmons PM, Robertson
EJ, Evans MJ and Rigby PW: The murine H19 gene is activated during
embryonic stem cell differentiation in vitro and at the time of
implantation in the developing embryo. Development. 113:1105–1114.
1991.PubMed/NCBI
|
|
11
|
Byun HM, Wong HL, Birnstein EA, Wolff EM,
Liang G and Yang AS: Examination of IGF2 and H19 loss of imprinting
in bladder cancer. Cancer Res. 67:10753–10758. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Berteaux N, Lottin S, Monté D, Pinte S,
Quatannens B, Coll J, Hondermarck H, Curgy JJ, Dugimont T and
Adriaenssens E: H19 mRNA-like noncoding RNA promotes breast cancer
cell proliferation through positive control by E2F1. J Biol Chem.
280:29625–29636. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kim SJ, Park SE, Lee C, Lee SY, Jo JH, Kim
JM and Oh YK: Alterations in promoter usage and expression levels
of insulin-like growth factor-II and H19 genes in cervical
carcinoma exhibiting biallelic expression of IGF-II. Biochim
Biophys Acta. 1586:307–315. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ariel I, Sughayer M, Fellig Y, Pizov G,
Ayesh S, Podeh D, Libdeh BA, Levy C, Birman T and Tykocinski ML:
The imprinted H19 gene is a marker of early recurrence in human
bladder carcinoma. Mol Pathol. 53:320–323. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li H, Yu B, Li J, Su L, Yan M, Zhu Z and
Liu B: Overexpression of lncRNA H19 enhances carcinogenesis and
metastasis of gastric cancer. Oncotarget. 5:2318–2329. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Edge SB and Compton CC: The American Joint
Committee on Cancer: The 7th edition of the AJCC cancer staging
manual and the future of TNM. Ann Surg Oncol. 17:1471–1474. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kiernan JA: Histological and Histochemical
Methods: Theory and Practice. 4th. Bloxham, UK: Scion; 2008
|
|
19
|
Chen S, Zhu J, Zuo S, Ma J, Zhang J, Chen
G, Wang X, Pan Y, Liu Y and Wang P: 1,25(OH)2D3 attenuates
TGF-β1/β2-induced increased migration and invasion via inhibiting
epithelial-mesenchymal transition in colon cancer cells. Biochem
Biophys Res Commun. 468:130–135. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Song H, Sun W, Ye G, Ding X, Liu Z, Zhang
S, Xia T, Xiao B, Xi Y and Guo J: Long non-coding RNA expression
profile in human gastric cancer and its clinical significances. J
Transl Med. 11:2252013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhou X, Yin C, Dang Y, Ye F and Zhang G:
Identification of the long non-coding RNA H19 in plasma as a novel
biomarker for diagnosis of gastric cancer. Sci Rep. 5:115162015.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tsang WP, Ng EK, Ng SS, Jin H, Yu J, Sung
JJ and Kwok TT: Oncofetal H19-derived miR-675 regulates tumor
suppressor RB in human colorectal cancer. Carcinogenesis.
31:350–358. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Vennin C, Spruyt N, Dahmani F, Julien S,
Bertucci F, Finetti P, Chassat T, Bourette RP, Le Bourhis X and
Adriaenssens E: H19 non coding RNA-derived miR-675 enhances
tumorigenesis and metastasis of breast cancer cells by
downregulating c-Cbl and Cbl-b. Oncotarget. 6:29209–29223.
2015.PubMed/NCBI
|
|
24
|
Liang WC, Fu WM, Wong CW, Wang Y, Wang WM,
Hu GX, Zhang L, Xiao LJ, Wan DC, Zhang JF and Waye MM: The lncRNA
H19 promotes epithelial to mesenchymal transition by functioning as
miRNA sponges in colorectal cancer. Oncotarget. 6:22513–22525.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ma C, Nong K, Zhu H, Wang W, Huang X, Yuan
Z and Ai K: H19 promotes pancreatic cancer metastasis by
derepressing let-7's suppression on its target HMGA2-mediated EMT.
Tumour Biol. 35:9163–9169. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Matouk IJ, Raveh E, Abu-lail R, Mezan S,
Gilon M, Gershtain E, Birman T, Gallula J, Schneider T, Barkali M,
et al: Oncofetal H19 RNA promotes tumor metastasis. Biochim Biophys
Acta. 1843:1414–1426. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tsanou E, Peschos D, Batistatou A,
Charalabopoulos A and Charalabopoulos K: The E-cadherin adhesion
molecule and colorectal cancer. A global literature approach.
Anticancer Res. 28:3815–3826. 2008.PubMed/NCBI
|
|
28
|
Costa LC, Leite CF, Cardoso SV, Loyola AM,
Faria PR, Souza PE and Horta MC: Expression of
epithelial-mesenchymal transition markers at the invasive front of
oral squamous cell carcinoma. J Appl Oral Sci. 23:169–178. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ouderkirk JL and Krendel M: Non-muscle
myosins in tumor progression, cancer cell invasion and metastasis.
Cytoskeleton (Hoboken). 71:447–463. 2014. View Article : Google Scholar : PubMed/NCBI
|
